Landfar Bio-medicine Co., Ltd (SHE:000504)

Landfar Bio-medicine Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 27, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Market Capitalization	3,346	2,756	3,614	3,627	5,795	3,814
Market Cap Growth	7.53%	-23.76%	-0.34%	-37.42%	51.96%	51.48%
Enterprise Value	3,333	2,522	3,679	3,774	6,136	3,928
Last Close Price	10.14	8.35	11.60	11.64	18.60	12.24
PE Ratio	-	-	-	-	-	467.67
PS Ratio	26.67	20.50	26.42	18.10	37.00	21.72
PB Ratio	9.23	9.77	11.86	45.23	52.53	28.36
P/TBV Ratio	18.80	11.81	14.20	696.61	726.09	276.47
P/FCF Ratio	274.82	-	119.05	24.27	77.13	-
P/OCF Ratio	220.15	574.87	99.63	21.80	54.11	-
EV/Sales Ratio	26.57	18.76	26.90	18.84	39.18	22.38
EV/EBITDA Ratio	-	-	-	-	-	164.63
EV/EBIT Ratio	-	-	-	-	-	191.56
EV/FCF Ratio	273.74	-	121.19	25.26	81.67	-
Debt / Equity Ratio	0.36	0.09	0.67	2.95	2.83	2.02
Debt / EBITDA Ratio	-	-	-	-	-	11.38
Debt / FCF Ratio	10.66	-	6.72	1.58	4.16	-
Net Debt / Equity Ratio	-0.37	-0.65	-0.96	0.21	1.44	1.52
Net Debt / EBITDA Ratio	9.54	14.36	8.70	-1.65	-8.62	8.55
Net Debt / FCF Ratio	-10.96	13.65	-9.61	0.11	2.11	-0.96
Asset Turnover	0.18	0.20	0.21	0.33	0.26	0.43
Inventory Turnover	1.39	2.00	5.92	9.64	3.62	4.78
Quick Ratio	1.18	1.18	1.41	0.89	0.68	0.69
Current Ratio	1.42	1.32	1.45	0.91	0.98	1.15
Return on Equity (ROE)	-5.48%	-8.16%	-24.31%	-30.93%	-27.04%	11.76%
Return on Assets (ROA)	-1.41%	-1.39%	-3.45%	-1.33%	-2.26%	3.11%
Return on Invested Capital (ROIC)	-15.25%	-27.62%	-66.71%	-7.06%	-7.22%	6.90%
Return on Capital Employed (ROCE)	-3.40%	-5.10%	-11.50%	-13.10%	-16.80%	14.90%
Earnings Yield	-0.19%	-0.72%	-0.78%	-0.34%	-0.33%	0.21%
FCF Yield	0.36%	-0.49%	0.84%	4.12%	1.30%	-5.55%
Payout Ratio	-	-	-	-	-	13.78%
Buyback Yield / Dilution	0.62%	-5.67%	-0.51%	2.30%	-17.27%	13.28%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.